Ultromics raised €11M in a Series A round in Feb 2018. The company is based in Oxford, UK. Investors in the round: Andre Crawford-Brunt, Dieter Spälti., Fushia and 5 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
